RenaSci is an independent company offering an integrated blend of consultancy and preclinical experimental services to the pharmaceutical industry. Our clients include pharma, biotech, virtual companies, and healthcare investors worldwide. Established in 2001, we focus on 4 key areas: abuse and dependence, CNS, obesity and diabetes.
RenaSci is led by Sharon Cheetham, Rob Jones and David Heal, who have more than 30 years of experience in the pharma industry and are supported by over 30 highly-qualified scientists, including a biostatistician, experienced in designing and validating biochemical and pharmacological techniques used in drug discovery and development. Consultancy is provided on all aspects of drug discovery, preclinical and clinical development, regulatory approval, intellectual property protection and market positioning. We have a successful track record in pharmaceutical R&D, having assisted in taking more than 30 candidates into clinical development and 10 drugs to the market.